F8 and hemophilia A: The treatment of hemophilia A is traditionally based on intravenous (i.v.)infusion of the deficient clotting FVIII concentrates (CFCs; replacement therapy), usually performed by the patients themselves or their caregivers in a home treatment setting [4], when bleeding episodes occur (on demand) or to prevent them (prophylaxis).